Unknown

Dataset Information

0

Maternal embryonic leucine zipper kinase: A novel biomarker and a potential therapeutic target of cervical cancer.


ABSTRACT: Maternal embryo leucine zipper kinase (MELK) is highly expressed in a variety of malignant tumors and involved in cell cycle regulation, cell proliferation, apoptosis, tumor formation etc However, the biological effects of MELK in cervical cancer are still uninvestigated. This study aimed to explore the expression of MELK in cervical cancer, as well as its effects on the proliferation, apoptosis, DNA damage repair on cervical cancer cell line in vitro and to provide novel ideas for further improving the clinical efficacy of cervical cancer. Immunohistochemistry, Western blot, RT-qPCR, CCK8, and immunofluorescence techniques were used to detect the expression of MELK in cervical cancer tissues, paracancerous tissues, and cervical cancer cell lines. Several cervical cancer cell lines were treated with MELK knockdown by siRNA and MELK selective inhibitor OTSSP167. The effects on proliferation, apoptosis, and colony formation capacity, and tumor cell DNA damage repair-related factor were detected in cell lines. Our data showed that the high expression rate of MELK in cervical cancer patients was 56.92%. MELK expression in cervical cancer samples was significantly higher than that in paraneoplastic tissues. Highly expressed MELK correlated with the cervical histopathological grading and greatly increased with the cervical histopathological grading, from normal cervix and cervical intraepithelial neoplasia to cervical cancer. Moreover, the abnormal expression of MELK was related to cervical cancer metastasis at early stage. The knockdown of MELK with siRNA and OTSSP167 had strong inhibition effects on the proliferation, apoptosis, and colony formation of cervical cancer cells. MELK knockdown could also aggravate the DNA damage of cervical cancer cells possibly by homologous recombination repair pathway. Therefore, MELK may be a predicting marker of poor prognosis of cervical cancer and may also be a new therapeutic target for cervical cancer, providing ideas for improving the therapeutic effect of cervical cancer.

SUBMITTER: Wang J 

PROVIDER: S-EPMC6246930 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC7471708 | biostudies-literature
| S-EPMC6398941 | biostudies-literature
| S-EPMC4868755 | biostudies-literature
| S-EPMC6717526 | biostudies-literature
| S-EPMC9235044 | biostudies-literature
| S-EPMC3724675 | biostudies-literature
| S-EPMC8820108 | biostudies-literature
| S-EPMC5792277 | biostudies-other
| S-EPMC4291735 | biostudies-literature
| S-EPMC6669820 | biostudies-literature